Amazon seeks $25 billion bond sale
Amazon.com (NASDAQ:AMZN) is looking to raise at least $25 billion through a U.S. dollar bond sale, according to Bloomberg News, as the company continues funding AI infrastructure investments.

Founder and CEO of Grafa, leading the company's vision to democratise financial data and empower investors with innovative tools.
Amazon.com (NASDAQ:AMZN) is looking to raise at least $25 billion through a U.S. dollar bond sale, according to Bloomberg News, as the company continues funding AI infrastructure investments.
Kailera Therapeutics (NASDAQ:KLRA) reported topline data from two Jiangsu Hengrui Pharmaceuticals Phase 3 trials of oral GLP-1 agonist HRS-7535/KAI-7535 in China, including mean weight loss of up to 11.1%.
Palladyne (NASDAQ:PDYN) executed a previously announced contract from the Air Force Research Laboratory (AFRL) to develop technology that enables autonomous defense systems to operate as a coordinated network.
The Trump administration's proposed Strategic Bitcoin Reserve has encountered an internal obstacle, with two federal departments competing for oversight of the initiative amid unresolved questions over legal authority, according to a Bloomberg report.
Equifax (NYSE:EFX) agreed to acquire Círculo de Crédito, a Mexico-based credit bureau, in a transaction valued at an enterprise value of $750 million and a purchase price of $825 million.
Smartphone sales in China fell 13% year over year during the month-long 618 shopping festival as higher memory costs pressured pricing and reduced promotional activity.
Bitcoin (CRYPTO:BTC) rebounded more than 8% to above US$64,000, but the recovery is facing pressure as Japan's 10-year government bond yield climbed to a 30-year high of 2.85%.
Yield Guild Games (YGG) will cut 35 employees and close its YGG Play publishing division as it shifts its focus from Web3 game publishing to supplying data for artificial intelligence models.
Imugene (ASX:IMU) secured firm commitments to raise $11.1 million via a share placement to fund its cancer clinical trials.
Nine Entertainment (ASX:NEC) executed a seven-year agreement for NRL and NRLW broadcast rights through to 2034.